Veronika Bouskova | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Dr. Veronika Bouskova | Molecular Biology | Best Researcher Award

Young scientist from Biomedical Centre in Pilsen, Czech Republic.

Dr. Veronika Boušková (née Brynychová) is a distinguished Czech researcher in the field of molecular biology and pharmacogenomics, with a particular focus on breast cancer biology and genetic variability. Her career combines academic research, laboratory-based investigation, and mentoring of young scientists. With a Ph.D. from the Third Faculty of Medicine at Charles University and over a decade of experience at premier research institutions like the Biomedical Center of the Faculty of Medicine in Pilsen and the National Institute of Public Health in Prague, she has established herself as a leading expert in transcriptomic analysis, caspase signaling, and the clinical implications of genetic variants in cancer prognosis and treatment. Dr. Boušková has authored or co-authored numerous articles published in high-impact journals and holds an impressive h-index of 13. Her research is notable for its integrative approach, combining molecular, cellular, and genetic data to better understand cancer progression and therapy resistance. She is also actively involved in academic education and mentoring, guiding the next generation of scientists. Her ability to conduct interdisciplinary research and her contributions to clinical and translational oncology make her a strong candidate for recognition through research awards.

Professional Profile

Education

Dr. Boušková has pursued a rigorous and interdisciplinary educational path rooted in biological sciences. She earned her Bachelor’s degree in Biology from the Faculty of Science at Charles University in 2008, followed by a Master’s degree in Biology, which she completed in 2010 through a collaborative program involving the Department of Anthropology and Human Genetics and the Institute of Archaeology at the Academy of Sciences. Her education culminated in a Ph.D. in Molecular and Cell Biology, Genetics, and Virology from the Third Faculty of Medicine, Charles University, which she pursued from 2010 to 2018. Her doctoral studies provided her with a comprehensive understanding of molecular and cellular mechanisms involved in human diseases, with a particular emphasis on cancer genetics and apoptosis. This strong educational foundation, grounded in both human genetics and molecular medicine, has enabled her to bridge basic scientific research with clinical applications. Additionally, Dr. Boušková’s involvement in interdisciplinary and international study programs reflects her commitment to continuous academic and professional growth, and has enriched her scientific perspective with cultural and methodological diversity.

Professional Experience

Dr. Boušková’s professional journey reflects her long-standing commitment to biomedical research and her evolving expertise in oncology-related molecular genetics. Since 2013, she has served as a Junior Researcher at the Biomedical Center, Faculty of Medicine in Pilsen, Charles University, where she works in the Laboratory of Pharmacogenomics. Simultaneously, she has maintained a research position at the National Institute of Public Health in Prague since 2010. Her work across both institutions focuses on investigating genetic variability, apoptosis-related genes, and microRNA expression in cancer patients, especially those with breast carcinoma. Between August 2019 and January 2022, she was on maternity leave, after which she resumed her scientific endeavors. Dr. Boušková has also been actively involved in teaching since 2015, conducting practical courses in biochemical laboratory techniques at the Faculty of Science, Charles University. She has mentored and consulted graduate students, contributing to their academic development and research projects. Her dual roles in research and education reflect a well-rounded professional profile combining laboratory excellence, mentorship, and scientific publication. Her sustained engagement in public health-oriented molecular research illustrates her commitment to improving healthcare outcomes through advanced biomedical science.

Research Interests

Dr. Veronika Boušková’s research interests center on the molecular and genetic mechanisms underlying cancer development and progression, with a particular emphasis on breast carcinoma. Her work delves into the regulation of apoptosis, the role of caspases and their isoforms, transcriptomic alterations, and microRNA expression profiles in tumor cells. She is especially interested in the pharmacogenomic implications of genetic variability, including single nucleotide polymorphisms and gene expression regulation that influence cancer prognosis and therapy response. Her integrative research also covers transcript and protein expression of genes involved in cell cycle control, epithelial-mesenchymal transition, and multidrug resistance. Additionally, Dr. Boušková has explored the impact of epigenetic modifications and miRNA-mediated gene regulation in breast cancer subtypes. Her interdisciplinary approach, combining molecular biology, genetics, pharmacology, and bioinformatics, contributes to identifying potential therapeutic targets and predictive biomarkers. She is committed to translational research, bridging laboratory findings with clinical practice to enhance personalized medicine strategies in oncology. Her recent publications reflect ongoing investigations into breast cancer microenvironment signaling, resistance mechanisms, and molecular diagnostics, demonstrating her ability to stay at the forefront of contemporary cancer research.

Research Skills

Dr. Boušková possesses a broad and advanced skill set in molecular biology and cancer genomics, honed over years of hands-on laboratory experience. Her research skills include gene expression analysis using RT-qPCR, microarray profiling, RNA sequencing, and high-resolution melting analysis. She is proficient in DNA/RNA extraction, reverse transcription, genotyping, and bioinformatics tools for analyzing transcriptomic and genomic datasets. Dr. Boušková is also skilled in cell culture techniques, protein expression studies, and functional assays relevant to apoptosis and cell signaling pathways. Her expertise extends to microRNA analysis and the use of pathway prediction software for understanding gene regulation networks. Moreover, she is well-versed in data interpretation, manuscript preparation, and collaborative research processes, contributing meaningfully to multidisciplinary teams. Her methodological rigor is evident from her contributions to over 25 peer-reviewed publications, many in high-impact journals. Additionally, she has experience in research project planning, laboratory management, and supervising student projects. Her continuous engagement with modern experimental technologies and analytical software ensures her research remains current and impactful. Her technical proficiency, analytical mindset, and collaborative approach make her a valuable contributor to complex research initiatives.

Awards and Honors

Dr. Boušková’s career includes several academic and research achievements, reflecting her dedication to high-quality scientific work. Notably, she was the recipient of a research grant from the Charles University Grant Agency (GAUK) from 2013 to 2015 for her project on the significance of apoptotic caspases and their splice variants in breast carcinoma. The project was successfully evaluated with all objectives fulfilled, highlighting her ability to manage and complete competitive research funding initiatives. Furthermore, she was awarded an internship opportunity in May 2014 at the National Research Institute of Chinese Medicine, under Dr. Yune-Fang Ueng’s laboratory, indicating her proactive pursuit of international research exposure. While there are no listings of specific awards such as national medals or society fellowships, her consistent record of high-impact publications, a strong citation index, and an h-index of 13 represent substantial academic honors in themselves. Her mentoring of graduate students and teaching contributions also reflect recognition within academic circles. Dr. Boušková’s recognition comes primarily through peer-reviewed scientific contributions and successful grant acquisitions, both of which underscore her qualifications for further accolades like the Best Researcher Award.

Conclusion

Dr. Veronika Boušková exemplifies the qualities of a top-tier biomedical researcher with a career marked by academic excellence, impactful research, and active mentorship. Her scientific focus on breast cancer genomics, microRNA regulation, and pharmacogenomics addresses some of the most pressing challenges in oncology today. With a strong publication record, an h-index of 13, and sustained research activity at reputable institutions, she has demonstrated not only productivity but also relevance and innovation in her field. Her interdisciplinary education and global research exposure further enhance her ability to navigate complex scientific questions. While expanding her international collaborations and taking on larger leadership roles in research consortia could elevate her profile further, her current contributions already reflect a researcher of significant merit and potential. Her dual commitment to research and education positions her as an influential figure within both academic and clinical research landscapes. In light of her qualifications, Dr. Boušková is highly deserving of recognition through awards such as the Best Researcher Award, which would not only honor her achievements but also support her future research endeavors aimed at improving cancer diagnosis and treatment.

Publications Top Notes

  1. Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer
    Authors: Petr Holý, Veronika Brynychová, Karolína Šeborová, Vojtěch Haničinec, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Pavel Souček, et al.
    Journal: Molecular Oncology
    Year: 2023
    Citations: 3
  2. Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer
    Authors: Ivona Krus, Veronika Brynychová, Viktor Hlaváč, Radka Václavíková, Maria Kováčová, Renata Koževnikovová, Kateřina Kopečková, Jannis Tornikidis, David Vrána, Jiří Gatěk, Pavel Souček
    Journal: Molecular Diagnosis and Therapy
    Year: 2022
    Citations: 2

 

Fatma Cavus Yonar | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Fatma Cavus Yonar | Molecular Biology | Best Researcher Award

Assistant Professor PhD from Istanbul University-Cerrahpasa Institute of Forensic Sciences and Legal Medicine Department of Science, Turkey

Dr. Fatma Çavuş Yonar is a distinguished academic and researcher in the field of forensic sciences with a specialization in analytical chemistry, forensic genetics, and toxicology. Currently serving as a Dr. Lecturer at the Istanbul University-Cerrahpaşa Institute of Forensic Sciences, she brings over a decade of experience in forensic research and education. Her scholarly contributions include extensive work on psychoactive substances, forensic genetics, and crime scene investigation methodologies. She is actively involved in scientific publishing, holding editorial board memberships for three international journals. Her work emphasizes interdisciplinary research, integrating nanotechnology, molecular biology, and advanced chromatography techniques. Dr. Yonar has published numerous book chapters and has contributed to foundational forensic science literature. Her dedication to scientific rigor and innovation makes her a strong candidate for the Best Researcher Award. She has played a critical role in training the next generation of forensic scientists while pushing the boundaries of conventional forensic analysis. Her consistent scholarly output and leadership in forensic science education and research are indicative of her significant contributions to the academic and scientific communities.

Professional Profile

Education

Dr. Fatma Çavuş Yonar’s academic journey reflects her deep commitment to forensic sciences and interdisciplinary learning. She began her higher education in the Department of Biology Education at Hacettepe University, graduating in 2009. She then pursued her Master of Science degree in Forensic Sciences at Istanbul University, completing her thesis on the simultaneous determination of fentanyl and norfentanil using LC-MS/MS techniques in 2012. Her doctoral studies were conducted at Istanbul University-Cerrahpaşa Institute of Forensic Sciences, where she obtained her PhD in 2018 with a dissertation investigating molecular transformations in pen inks under various environmental conditions. Dr. Yonar’s academic trajectory showcases a clear progression from foundational science education to highly specialized forensic research. Her educational background has provided her with the necessary skills to address complex analytical problems in forensic science, with a particular emphasis on toxicology, molecular biology, and analytical chemistry. Her interdisciplinary expertise is evident in her research and teaching activities and aligns well with the evolving demands of modern forensic investigation.

Professional Experience

Dr. Fatma Çavuş Yonar has accumulated extensive experience in academia and research through her long-standing affiliation with Istanbul University. Her professional career began in 2011 as a Research Assistant at the Istanbul University Institute of Forensic Sciences. Over the next seven years, she actively contributed to research, publications, and laboratory training for postgraduate students. In 2020, she was appointed as a Dr. Lecturer at Istanbul University-Cerrahpaşa Institute of Forensic Sciences, where she currently teaches and supervises research in the Department of Science. Her responsibilities include curriculum development, guiding thesis projects, and collaborating on interdepartmental research initiatives. Dr. Yonar also serves on editorial boards for multiple forensic science journals, reflecting her standing in the academic community. Her practical experience extends to forensic genetics, toxicology, and the analysis of psychoactive substances. She has co-authored many influential book chapters and has been involved in numerous collaborative research projects. Her dual role as an educator and active researcher makes her a vital asset to the academic and scientific communities.

Research Interests

Dr. Fatma Çavuş Yonar’s research interests span a broad spectrum of forensic science disciplines, particularly forensic toxicology, analytical chemistry, forensic genetics, and crime scene investigation. She is especially focused on the molecular and chemical analysis of psychoactive substances and forensic trace evidence, such as ink and biological material. Her doctoral research explored the stability and transformation of ink molecules under various environmental conditions, demonstrating her interest in both chemical characterization and environmental influences on forensic samples. She is also actively engaged in developing analytical techniques using nanotechnology and molecular diagnostics, with a focus on applications in forensic genetics and toxicology. Another significant area of her research is the analysis of designer drugs and new-generation psychoactive substances using chromatographic techniques. Her interdisciplinary approach allows her to bridge the gap between classical forensic methodologies and modern molecular technologies. Dr. Yonar’s work contributes to improved methodologies for evidence evaluation and supports advancements in forensic identification, substance detection, and expert testimony.

Research Skills

Dr. Fatma Çavuş Yonar possesses a robust set of research skills that are essential for cutting-edge forensic investigations. She is proficient in advanced analytical techniques, including liquid chromatography-tandem mass spectrometry (LC-MS/MS), gas chromatography, and spectroscopic methods. Her expertise extends to molecular biology tools, forensic DNA analysis, and epigenetics. She has practical experience in RNA-based identification and the forensic examination of biological and digital evidence. Her skills are further demonstrated through her contributions to interdisciplinary book chapters and her research on nanoscience applications in forensic genetics. Dr. Yonar is also experienced in handling statistical methods for evaluating forensic genetic data, which enhances the reliability of her research outcomes. She has conducted extensive research on psychoactive substances and their legal implications, combining chemical analysis with forensic context. Her research skills are not only technical but also conceptual, as she effectively integrates science with forensic interpretation, making her research outputs both academically rigorous and practically applicable.

Awards and Honors

While specific awards and honors were not explicitly listed in the profile provided, Dr. Fatma Çavuş Yonar’s professional achievements and responsibilities are indicative of significant peer recognition. Her appointment as an editorial board member for three international journals in 2024 highlights her leadership and expertise in the field. Editorial roles are typically reserved for well-established researchers who have demonstrated consistent contributions and hold influence in their disciplines. In addition, her longstanding academic role at Istanbul University-Cerrahpaşa, along with her published chapters in internationally recognized forensic science books, reflects the high regard in which she is held by her peers. These professional appointments and scholarly contributions collectively suggest a commendable level of recognition and respect in the scientific community, underscoring her qualification for prestigious awards such as the Best Researcher Award.

Conclusion

Dr. Fatma Çavuş Yonar is a highly qualified candidate for the Best Researcher Award, demonstrating a sustained commitment to forensic science through education, research, and academic service. Her work integrates analytical chemistry, molecular biology, and forensic toxicology, enabling her to contribute valuable advancements to both theory and practice. With a strong foundation in research methodology, she has produced high-impact scholarly work, participated in interdisciplinary collaborations, and mentored upcoming forensic scientists. Her editorial responsibilities in international journals and contributions to forensic literature further validate her leadership in the field. While a more detailed list of honors could further strengthen her profile, her current accomplishments already reflect a well-established and impactful career. Dr. Yonar exemplifies the qualities of an innovative and dedicated researcher, and her recognition with this award would acknowledge her significant role in advancing forensic science and promoting academic excellence.

Publications Top Notes

  • Title: The other side of the paper as the evidence: impacts of fingermark development reagents on fingermark development and cocaine amount in cocaine-impregnated paper
    Journal: Forensic Science, Medicine and Pathology
    Date: 2024-10-17
    DOI: 10.1007/s12024-024-00897-2
    Contributors: Yakup Gulekci, Fatma Cavus Yonar, Pınar Efeoglu Ozseker, İsmail Ethem Gören, Nebile Daglioglu

  • Title: Short-cut route validated for monitoring fentanyl and its metabolite in urine using LC–MS/MS, in a wide concentration range
    Journal: Future Journal of Pharmaceutical Sciences
    Date: 2024-07-04
    DOI: 10.1186/s43094-024-00657-7
    Contributors: Fatma Cavus Yonar, Beril Anılanmert, Munevver Acikkol

  • Title: The effect of fingerprint enhancement methods applied on adhesive surfaces on DNA recovery: a preliminary study
    Journal: Journal of Scientific Reports-A
    Date: 2024-03-31
    DOI: 10.59313/jsr-a.1375939
    Contributors: Fatma Cavus Yonar, Yakup Gülekçi

  • Title: False Positives in Luminal Testing
    Journal: Black Sea Journal of Engineering and Science
    Date: 2024-01-15
    DOI: 10.34248/bsengineering.1391613
    Contributors: Yakup GÜLEKÇİ, Fatma CAVUS YONAR

  • Title: Speedy Gonzales analysis method in one drop of beverage, for crimes committed with drugs from three different groups
    Journal: Analytical Sciences
    Date: 2023-06
    DOI: 10.1007/s44211-023-00282-z
    Contributors: Beril Anilanmert, Fatma Cavus Yonar

  • Title: Comparison of methods to develop fingerprints on papers impregnated with AB‐PINACA and AB‐FUBINACA
    Journal: Journal of Forensic Sciences
    Date: 2022-03
    DOI: 10.1111/1556-4029.14926
    Contributors: Yakup Gulekci, Pınar Efeoglu Ozseker, Fatma Cavus Yonar, Nebile Daglioglu

  • Title: DNA profiling for forensic identification in Bulgarian Turks
    Journal: Medicine Science | International Medical Journal
    Date: 2021
    DOI: 10.5455/medscience.2020.12.254
    Contributor: Fatma Cavus Yonar

  • Title: Who touched the document?: A new overall strategy for collection and identification of DNA from the questioned documents as a supportive evidence
    Journal: ELECTROPHORESIS
    Date: 2021-10
    DOI: 10.1002/elps.202100192
    Contributor: Fatma Cavus Yonar

  • Title: Assessment of 13 Single Nucleotide Polymorphisms Loci for Identification in Forensic Sciences for Turkish Population
    Journal: International Journal of Biology and Chemistry
    Date: 2021-06
    DOI: 10.26577/ijbch.2021.v14.i1.05
    Contributor: Fatma Cavus Yonar

  • Title: CONFORMITY ASSESSMENT OF TEMPERATURE MEASURING DEVICES USED IN FORENSIC SCIENCE LABORATORIES UNDER ISO/IEC 17025: 2017
    Journal: International Journal of Advanced Research
    Date: 2021-06-30
    DOI: 10.21474/ijar01/12986
    Contributor: Fatma Cavus Yonar

Shane Scott | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Dr. Shane Scott | Molecular Biology | Best Researcher Award

Medical Student from The Ohio State College of Medicine, United States

Dr. Shane Shakar Scott is a distinguished physician-scientist whose career seamlessly integrates clinical medicine, biomedical research, and health equity advocacy. Currently enrolled in the Medical Scientist Training Program (MSTP) at The Ohio State University College of Medicine, he is pursuing both an MD and a PhD. His doctoral research focuses on the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure, contributing significantly to the field of cardio-oncology. Dr. Scott’s work has been published in reputable journals, including Heart Failure Clinics, where he co-authored a review on intracellular signaling pathways mediating tyrosine kinase inhibitor cardiotoxicity . Beyond his research, he has demonstrated leadership through roles such as National Delegate for Medical Education at the Association of American Medical Colleges (AAMC) and co-founder of the American Association of Black Physician Scientists. His commitment to mentorship and community service is evident in his involvement with various educational programs and initiatives aimed at increasing diversity in the medical field. Dr. Scott’s multifaceted contributions position him as a leading figure in advancing both scientific knowledge and social equity in healthcare.

Professional Profile

Education

Dr. Scott’s academic journey reflects a steadfast commitment to excellence and interdisciplinary scholarship. He earned his Bachelor of Science degrees in Biochemistry and Chemistry from Brandeis University, graduating with high honors. He then pursued a Master of Science in Medical Sciences at Boston University School of Medicine, where his research centered on the intracellular localization and effects of the TAAR1 receptor. Currently, Dr. Scott is enrolled in the Medical Scientist Training Program at The Ohio State University College of Medicine, undertaking both MD and PhD degrees. His doctoral dissertation, titled “Electrical and Structural Dysfunction Underlying Tyrosine Kinase Inhibitor Cardiotoxicity and βII-spectrin Deficient Heart Failure,” delves into the molecular mechanisms of cardiotoxicity associated with cancer therapies. This rigorous academic foundation equips Dr. Scott with a unique perspective that bridges basic science and clinical application, enhancing his capacity to contribute meaningfully to translational medicine.

Professional Experience

Dr. Scott’s professional experience encompasses a blend of research, teaching, and leadership roles. As a graduate trainee at the Davis Heart and Lung Research Institute, he investigated the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure. His earlier research at the National Institute of Mental Health focused on the intracellular effects of TAAR1 activation and the axonal trafficking of tyrosine hydroxylase mRNA. In addition to his research endeavors, Dr. Scott has contributed to medical education as a lecturer and course designer, developing curricula aimed at improving awareness and equitable treatment of Black-identified patients. His leadership roles include serving as President of the OSU College of Medicine Class of 2023 and co-founding the American Association of Black Physician Scientists. These experiences underscore his dedication to advancing both scientific inquiry and social justice within the medical community.

Research Interests

Dr. Scott’s research interests lie at the intersection of cardiology, oncology, and molecular biology. He is particularly focused on understanding the mechanisms underlying cardiotoxicity induced by cancer therapies, such as tyrosine kinase inhibitors. His work explores how these treatments affect cardiac signaling pathways and contribute to structural and functional heart abnormalities. Additionally, Dr. Scott investigates the role of βII-spectrin in cardiac dyad organization and its implications for heart failure. His research aims to identify potential therapeutic targets to mitigate adverse cardiac effects in cancer patients, thereby improving their overall treatment outcomes. Through his studies, Dr. Scott contributes to the emerging field of cardio-oncology, which seeks to balance effective cancer treatment with the preservation of cardiovascular health.

Research Skills

Dr. Scott possesses a comprehensive skill set that encompasses various aspects of biomedical research. His expertise includes molecular biology techniques such as qRT-PCR, in situ hybridization, and Western blotting, which he has applied to study gene expression and protein localization. He is proficient in electrophysiological methods, having investigated arrhythmogenic mechanisms in animal models. Dr. Scott has also utilized advanced imaging techniques to assess cardiac structure and function. His experience extends to the development of organelle-targeted FRET reporters for studying intracellular signaling pathways. Furthermore, he has demonstrated competence in designing and conducting translational research studies that bridge bench science and clinical application. These skills enable Dr. Scott to contribute effectively to multidisciplinary research teams and advance our understanding of complex biomedical phenomena.

Awards and Honors

Dr. Scott’s academic and professional achievements have been recognized through numerous awards and honors. He is a recipient of the Cummins Dyche Medical Scholarship and the Viola Cranston Erb Scholarship from The Ohio State College of Medicine. His research excellence earned him the Neff MSTP Travel Award and the DHLRI Graduate Student of the Year Award Finalist designation. Dr. Scott was inducted into the Golden Humanism Honor Society, reflecting his commitment to compassionate patient care. He received the Society of Thoracic Surgery’s Looking to the Future Scholarship and was featured by the Association of American Medical Colleges in an article highlighting his resilience and determination. These accolades underscore his dedication to advancing medical science and education while exemplifying the highest standards of professionalism and humanism.

Conclusion

Dr. Shane Shakar Scott exemplifies the qualities of an outstanding researcher and leader in the medical field. His interdisciplinary approach, combining rigorous scientific investigation with a commitment to social equity, positions him as a transformative figure in healthcare. Through his research on cardiotoxicity and heart failure, Dr. Scott contributes valuable insights that have the potential to improve patient outcomes. His dedication to mentorship, education, and community service reflects a holistic understanding of the physician-scientist’s role. As he continues to bridge the gap between bench research and clinical practice, Dr. Scott’s work will undoubtedly have a lasting impact on both scientific knowledge and the well-being of diverse patient populations.

Publications Top Notes

  1. Title: Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity
    Journal: Heart Failure Clinics
    Year: 2022 (June)
    DOI: 10.1016/j.hfc.2022.02.003
    Author: Shane Shakar Scott

  2. Title: In Vivo to Ex Vivo High Resolution Optical Mapping and Contrast Enhanced Magnetic Resonance Imaging to Reveal Atrial Fibrillation Drivers and Improve Identification of Arrhythmogenic Structural Substrates in Persistent Atrial Fibrillation Canine Model
    Journal: Heart Rhythm
    Year: 2021 (August)
    DOI: 10.1016/j.hrthm.2021.06.937
    Author: Shane Shakar Scott

  3. Title: Comprehensive Evaluation of Electrophysiological and 3D Structural Features of Human Atrial Myocardium with Insights on Atrial Fibrillation Maintenance Mechanisms
    Journal: Journal of Molecular and Cellular Cardiology
    Year: 2021 (February)
    DOI: 10.1016/j.yjmcc.2020.10.012
    Author: Shane Shakar Scott

  4. Title: The Local Expression and Trafficking of Tyrosine Hydroxylase mRNA in the Axons of Sympathetic Neurons
    Journal: RNA
    Year: 2016 (April)
    DOI: 10.1261/rna.053272.115
    Authors: Noreen M. Gervasi; Shane S. Scott; Armaz Aschrafi; Jenna Gale; Sanah N. Vohra; Margaret A. MacGibeny; Amar N. Kar; Anthony E. Gioio; Barry B. Kaplan

Mehwish Zehravi | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Mehwish Zehravi | Molecular Biology | Best Researcher Award

Assistant Professor at Al-Tibri Medical College, Pakistan

Dr. Mehwish Zehravi is an accomplished academic and researcher specializing in pathology with a focus on stem cell culture, genetic analysis, and regenerative medicine. Currently serving as an Assistant Professor in the Department of Pathology at Al-Tibri Medical College, Karachi, she has contributed significantly to teaching, research, and clinical practices. Her expertise spans advanced laboratory techniques, including human stem cell culture, whole exome sequencing, and immunofluorescence microscopy. With a strong academic foundation, Dr. Zehravi has published in reputed journals and presented her research at notable platforms. Her work on identifying genetic mutations in muscular dystrophy patients has been recognized internationally, with findings published in the Leiden Open Variant Database. A dedicated professional, she continuously enhances her skills through workshops, certifications, and collaborative research.

Professional Profile

Education

Dr. Zehravi holds an M.Phil. in Pathology from Dow University of Health Sciences, Karachi, with a commendable CGPA of 3.48, achieved in 2020. She earned her M.B.B.S. from the same institution in 2012, securing a CGPA of 3.06. Her academic journey also includes pre-medical studies at B.A.M.M. P.E.C.H.S. Govt. College for Women, Karachi, and matriculation at St. Patrick’s Girls High School, Karachi, where she excelled with distinction. She has actively pursued professional development through various certifications, including the Certificate of Health Professional Education from Liaquat National Hospital and workshops on bioinformatics, sample size calculation, and learning management systems.

Professional Experience

Dr. Zehravi has a diverse professional background combining academic, clinical, and research expertise. Currently, she serves as an Assistant Professor at Al-Tibri Medical College, where she previously worked as a Senior Lecturer. Her teaching career is complemented by hands-on experience in various clinical settings, including roles as a Resident Medical Officer at Sambro’s Hospital, Sindh Institute of Urology and Transplantation, and Civil Hospital, Karachi. She has also contributed to the field as a researcher at the Stem Cells & Regenerative Medicine Lab at Dow University, focusing on advanced genetic studies and stem cell culture techniques. Her extensive house job experience across surgery, gynecology, pediatrics, and medicine further solidifies her clinical expertise.

Research Interests

Dr. Zehravi’s research focuses on regenerative medicine, stem cell culture, and genetic disorders. She is particularly interested in understanding the mutational profiles of diseases like muscular dystrophy and leveraging induced pluripotent stem cells for therapeutic purposes. Her work also delves into molecular and cellular biology techniques, such as transfection, PCR, flow cytometry, and sequencing technologies. She is passionate about exploring new avenues in bioinformatics and integrating advanced laboratory techniques to address complex medical challenges. Dr. Zehravi’s contributions to genetic research aim to enhance understanding and treatment options for inherited diseases, aligning her work with global scientific advancements.

Research Skills

Dr. Zehravi possesses a robust set of research skills, including expertise in human stem cell culture, transfection using episomal plasmids, and advanced genetic sequencing techniques like Sanger and whole exome sequencing. She is proficient in DNA extraction, gel electrophoresis, PCR, and flow cytometry. Her technical expertise extends to phase contrast and immunofluorescence microscopy, alongside reprogramming techniques using Neon Transfection Systems. Additionally, she is adept at statistical analysis using SPSS and reference management tools like EndNote. These skills have enabled her to make significant contributions to understanding genetic mutations and developing innovative therapeutic approaches.

Awards and Honors

Dr. Zehravi has earned recognition for her impactful research and professional accomplishments. Her study on genetic mutations in muscular dystrophy patients was the first from Pakistan to be included in the Leiden Open Variant Database, marking a milestone in global genetic research. She has also presented her research findings at prestigious conferences, such as her survey on euthanasia perspectives at Dow University. Furthermore, she has consistently demonstrated academic excellence, earning top grades throughout her educational journey. Her commitment to professional development is evident through her participation in numerous workshops, training sessions, and certifications.

Conclusion

Dr. Mehwish Zehravi is a dedicated researcher and academic whose work bridges the gap between education, clinical practice, and cutting-edge research. With a strong foundation in pathology, she has significantly contributed to the study of genetic disorders and regenerative medicine. Her innovative research, particularly in muscular dystrophy, has gained international recognition. Alongside her academic and research pursuits, Dr. Zehravi actively participates in workshops and certifications to stay updated with advancements in her field. With her exceptional skills and passion for medical research, Dr. Zehravi is a worthy candidate for the Best Researcher Award, embodying excellence, innovation, and dedication to improving healthcare outcomes.

Publication Top Notes

  1. Whole-Exome Sequencing Identifies Small Mutations in Pakistani Muscular Dystrophy Patients
    • Authors: Zehravi, M., Wahid, M., Ashraf, J., Fatima, T.
    • Year: 2021
    • Citations: 1
  2. Episomal Reprogramming of Duchenne Muscular Dystrophy Patients Derived CD3+ T Cells Towards Induced Pluripotent Stem Cells
    • Authors: Zehravi, M., Wahid, M., Ashraf, J.
    • Year: 2021
    • Citations: 1

 

Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Followship at University of Zakho, United Kingdom

Dr. Khalid Subhi Ibrahim, an Assistant Professor at the University of Zakho, is a distinguished researcher in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. With a Ph.D. from Glasgow Caledonian University, his work focuses on understanding gut bacterial communities in obesity, Type 2 diabetes, and other health conditions using cutting-edge techniques like next-generation sequencing and bioinformatics tools such as QIIME2 and PICRUSt2. He has led significant collaborations, including projects with the Massachusetts Institute of Technology (MIT) and Kiel University, Germany, and has contributed to global microbiome conservancy efforts. An Editor-in-Chief of SJUOZ and a committee member of MVIF, Dr. Ibrahim’s expertise extends to training scientists, publishing research, and presenting at international conferences. His diverse contributions reflect his commitment to advancing microbiome research and its applications in health and environmental sciences.

Professional Profile

Education

Dr. Khalid Subhi Ibrahim holds a Ph.D. in Life Sciences from Glasgow Caledonian University, UK (2013-2017), where his research focused on “Biochemical Interactions Between the Gut Microbiome and Host in Obesity/Type 2 Diabetes.” He also completed an MSc in Veterinary Pathology specializing in fish diseases at the University of Duhok, Kurdistan Region, Iraq (2006-2008), presenting a thesis on pathological studies in common carp infected with Aeromonas hydrophila. Dr. Khalid earned his Bachelor of Veterinary Medicine (Medicine and Surgery) from the same institution in 2004. Additionally, he attended a Pre-sessional English Language program at Glasgow University in 2012. Throughout his education, Dr. Khalid developed extensive expertise in microbiology, molecular diagnostics, and bioinformatics. His academic foundation reflects a robust combination of veterinary science, microbiological research, and advanced molecular techniques, forming the basis of his prolific career in microbiome studies and biomedical sciences.

Professional Experience

Dr. Khalid Subhi Ibrahim is an accomplished Assistant Professor with extensive experience in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and gut microbiome research. He has a strong background in utilizing advanced molecular techniques such as next-generation sequencing, bioinformatics, and 16S rRNA analysis to explore microbiota in various contexts, including obesity, Type 2 diabetes, pollution, and animal health. Dr. Ibrahim has collaborated with prestigious institutions such as Glasgow Caledonian University, Monash University, MIT, and Universitätsklinikum Schleswig-Holstein on numerous international projects. His expertise extends to training scientists, supervising research students, and contributing to impactful research. Additionally, he has served as Editor-in-Chief of the SJUOZ journal and actively participated in global microbiome conservancy initiatives. With a proven track record of research, teaching, and collaboration, Dr. Ibrahim is dedicated to advancing microbiome science and fostering academic excellence.

Research Interest

Dr. Khalid Subhi Ibrahim’s research interests focus on biomedical sciences, with expertise in diagnostic and molecular microbiology, clinical biochemistry, and bioinformatics. His work centers on understanding the role of gut microbiome changes in health and disease, particularly in obesity, Type 2 diabetes mellitus (T2DM), and pollution. Employing advanced molecular techniques and next-generation sequencing, he investigates microbiota in humans, animals, soils, and wastewater, emphasizing 16S rRNA analysis using tools like QIIME2 and PICRUSt2. Dr. Ibrahim’s research extends to metagenomics and functional analysis of microbiomes in various contexts, including colorectal cancer, nosocomial infections in children, and zoonotic diseases in livestock. His collaborations span globally, engaging with institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and the University of Tartu. Driven by a passion for microbiome research, he aims to advance in silico analysis techniques, enriching the understanding of microbial ecosystems and their impacts on human and environmental health.

Award and Honor

Dr. Khalid Subhi Ibrahim, a distinguished microbiologist and academic, has earned recognition for his remarkable contributions to biomedical sciences, particularly in microbiome research. Serving as Assistant Professor at the University of Zakho, Dr. Ibrahim leads the Global Microbiome Conservancy in Iraq and holds the prestigious position of Editor-in-Chief for the Scientific Journal of University of Zakho (SJUOZ). His collaborative endeavors span globally, involving partnerships with renowned institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and Monash University. Dr. Ibrahim’s accolades include delivering impactful presentations at international conferences and publishing high-impact research on gut microbiota’s role in obesity, Type 2 diabetes, and pollution. His expertise in bioinformatics and next-generation sequencing has advanced the understanding of microbial communities in diverse ecosystems. Committed to mentorship and innovation, Dr. Ibrahim’s career reflects a dedication to advancing scientific knowledge and fostering international collaboration in microbiome science.

Conclusion

Dr. Khalid Subhi Ibrahim is a distinguished researcher with expertise in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. His extensive academic and professional journey reflects a strong commitment to advancing biomedical sciences, with a particular focus on gut microbiome research in relation to obesity, Type 2 diabetes, pollution, and colorectal cancer. Dr. Ibrahim’s collaborative projects with esteemed institutions, including MIT and the University of Tartu, underscore his global impact and research network. His proficiency in cutting-edge techniques such as next-generation sequencing, bioinformatics, and microbiota analysis highlights his technical expertise. Additionally, his dedication to knowledge dissemination through teaching, supervising, and publishing further solidifies his contributions to science. While Dr. Ibrahim’s focus on microbiome studies is commendable, expanding his publication record in high-impact journals would further strengthen his academic influence. Overall, Dr. Khalid Subhi Ibrahim demonstrates exceptional merit as a candidate for the Best Researcher Award.

Publications Top Noted

  1. Title: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    Authors: Naghavi, M., Ong, K.L., Aali, A., Wool, E.E., Murray, C.J.L.
    Year: 2024
    Citations: 259
  2. Title: Retrospective analysis of pediatric sepsis and the burden of antimicrobial resistance in Duhok, Kurdistan Region of Iraq
    Authors: Ibrahim, D.R., Saadi, A.T., Yahya, N.B., Alarsalani, B.K., Ibrahim, K.S.
    Year: 2024
    Citations: 0
  3. Title: Global Burden of Cardiovascular Diseases and Risks, 1990-2022
    Authors: Mensah, G.A., Habtegiorgis Abate, Y., Abbasian, M., Murray, C.J.L., Roth, G.A.
    Year: 2023
    Citations: 295
  4. Title: Chinese medicine, Qijudihuang pill, mediates cholesterol metabolism and regulates gut microbiota in high-fat diet-fed mice, implications for age-related macular degeneration
    Authors: Cao, Y., Ibrahim, K.S., Li, X., Craft, J.A., Shu, X.
    Year: 2023
    Citations: 0
  5. Title: Molecular Characterization of Extended Spectrum β-Lactamase (ESBL) and Virulence Gene-Factors in Uropathogenic Escherichia coli (UPEC) in Children in Duhok City, Kurdistan Region, Iraq
    Authors: Hasan, S.M., Ibrahim, K.S.
    Year: 2022
    Citations: 5
  6. Title: In silico analysis of bacterial metabolism of glutamate and GABA in the gut in a rat model of obesity and type 2 diabetes
    Authors: Ibrahim, K.S., Bourwis, N., Dolan, S., Craft, J.A.
    Year: 2022
    Citations: 2
  7. Title: Effect of a TSPO ligand on retinal pigment epithelial cholesterol homeostasis in high-fat fed mice, implication for age-related macular degeneration
    Authors: Biswas, L., Ibrahim, K.S., Li, X., Craft, J., Shu, X.
    Year: 2021
    Citations: 16
  8. Title: Transcriptome-wide changes associated with the reproductive behaviour of male guppies exposed to 17α-ethinyl estradiol
    Authors: Saaristo, M., Craft, J.A., Tyagi, S., Ibrahim, K.S., Wong, B.B.M.
    Year: 2021
    Citations: 8
  9. Title: Prevalence and Hemato-biochemical Studies on Theileriosis in Naturally Infected Cattle in Erbil Province
    Authors: Aziz, K., Qader, N., Ibrahim, K.
    Year: 2021
    Citations: 3
  10. Title: Etifoxine reverses weight gain and alters the colonic bacterial community in a mouse model of obesity
    Authors: Ibrahim, K.S., Craft, J.A., Biswas, L., Spencer, J., Shu, X.
    Year: 2020
    Citations: 15

 

 

Francisca Louenny Alves Cardoso | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Ms. Francisca Louenny Alves Cardoso | Molecular Biology | Best Researcher Award

PhD student, Federal University of Piauí , Brazil

Francisca Louenny Alves Cardoso is a promising researcher currently pursuing a Ph.D. in Applied Technologies for Regional Animal Interests at Universidade Federal do Piauí, Brazil. With a Master’s degree in the same field, she specializes in mesenchymal stem cells, osteogenesis, and biomaterials. Francisca has contributed significantly to her area through multiple publications in scientific journals, exploring topics such as cytotoxicity and biomaterial development. She has received recognition for her work, including an honorable mention at an international congress. Her professional experience includes roles in various health laboratories and participation in impactful research projects, notably in epidemiological profiles of visceral leishmaniasis. Additionally, she actively engages in continuous education and has a specialization in Hematology and Hemotherapy. With strong communication skills in Portuguese and reasonable proficiency in English and Spanish, Francisca is well-prepared for collaborative research in biotechnology and biomedical engineering.

Profile:

Education

Francisca Louenny Alves Cardoso is currently pursuing a Ph.D. in Applied Technologies for Animals of Regional Interest at the Federal University of Piauí (UFPI), Brazil, with a focus on mesenchymal stem cells and biomaterials. She completed her Master’s degree in the same field at UFPI in 2023, where she explored the toxicity and osteogenesis related to laponite and scaffolds. Additionally, she holds a specialization in Hematology and Hemotherapy from União das Américas and a Bachelor’s degree in Biomedicine from Faculdade Maurício de Nassau, completed in 2019. Throughout her education, she has engaged in various scientific and professional development courses, including entrepreneurship and advanced reading in English, enhancing her expertise in biotechnology and biomedical engineering. Her academic background is further complemented by participation in international scientific jornadas, reflecting her commitment to ongoing learning and research in her field.

Professional Experience

Francisca Louenny Alves Cardoso has gained valuable professional experience in the field of biotechnology through various roles. In 2019, she served as an intern at both the Lablife Laboratory and the Central Public Health Laboratory of Piauí, where she contributed to research and laboratory operations. From 2021 to 2023, she worked at UNIFACID, initially under employment laws and later participating in project activities. Her research projects include epidemiological profiles of visceral leishmaniasis in Brazil and clinical assessments related to reduced seminal quality in men. Throughout her academic journey, Francisca has also engaged in teaching roles, providing her with a comprehensive understanding of both practical and theoretical aspects of biotechnology. Her diverse experiences have equipped her with a strong foundation in biological sciences, making her a promising candidate for further contributions to the field.

Research Skills

Francisca Louenny Alves Cardoso possesses a robust skill set in biotechnology, particularly in the fields of stem cell research, biomaterials, and medical engineering. Her research focuses on mesenchymal stem cells, osteogenesis, and the development of biocompatible scaffolds, showcasing her expertise in experimental applications involving regional animal species. With a strong foundation in both theoretical and practical aspects of biological sciences, she has actively contributed to several research projects, including studies on the cytotoxicity and genotoxicity of various materials. Cardoso’s proficiency in English, Spanish, and Portuguese enhances her ability to collaborate internationally, while her presentations at conferences and publications in scientific journals reflect her commitment to advancing knowledge in her field. Additionally, her ongoing Ph.D. work at the Universidade Federal do Piauí underscores her dedication to innovative research in biotechnology and biomedical engineering, positioning her as a valuable contributor to scientific advancements.

Award and Recognition

Francisca Louenny Alves Cardoso has made significant strides in the field of biotechnology, particularly in her research on mesenchymal stem cells and biomaterials. Her dedication to scientific excellence was recognized in 2019 when she received an honorable mention for her presentation on “Células Progenitoras Renais de Suínos” at the International Congress of Health Students and Professionals. This accolade highlights her ability to contribute valuable insights to her field. Additionally, her active participation in various scientific congresses and her authorship of multiple peer-reviewed articles further demonstrate her commitment to advancing knowledge in biological sciences. As she progresses through her Ph.D. studies, her ongoing contributions continue to establish her as a promising researcher within her specialization. Her achievements reflect not only her personal dedication but also her potential to impact the biotechnology landscape significantly. 🌟🔬

Conclusion

Francisca Louenny Alves Cardoso exemplifies the qualities of a strong candidate for the Best Researcher Award. Her robust educational background, impactful research contributions, and recognition in the scientific community position her as a promising researcher in the field of biotechnology. By focusing on expanding her networking opportunities and enhancing her grant-writing skills, she could further elevate her research career and contribute significantly to her field.

Publication Top Notes

  1. Title: Aspectos epidemiológicos associados à ocorrência de casos de esquistossomose no Brasil nos anos de 2007 a 2017
    Authors: André Cardoso Tavares; Francisca Louenny Alves Cardoso; Vitória Silva de Aragão; Tayana Vívian Ribeiro Bastos; Helder Matheus Alves Fernandes; Elane da Silva Barbosa; Éllen Nayane Beserra Torres; Amália Gonçalves Arruda; Márcia Jaínne Campelo Chaves; Maria Lucilane da Silva Sales
    Year: 2024
    Type: Book chapter
    DOI: 10.36926/editorainovar-978-65-5388-2133_004
    ISBN: 9786553882133
  2. Title: Cytotoxicity and genotoxic impacts of LAPONITE® on murine adipose stem cells
    Authors: Francisca L.A. Cardoso; Letícya L.S. Soares; Danielle B.A. Silva; Napoleão M. Argôlo Neto; Edson C. Silva Filho; Adalberto S. Silva; Dayseanny O. Bezerra; Maria S.P. Cruz; Felipe C. Nunes; Wanderson G.G. Melo et al.
    Year: 2024
    Journal: Applied Clay Science
    DOI: 10.1016/j.clay.2024.107572
    ISSN: 0169-1317
  3. Title: Development of a new biomaterial based on cashew tree gum (Anarcadium occidentale L.) enriched with hydroxyapatite and evaluation of cytotoxicity in adipose-derived stem cell cultures
    Authors: Lorenna Bastos Nogueira da Rocha; Ricardo Barbosa Sousa; Marcus Vinicius Beserra dos Santos; Napoleão Martins Argolo Neto; Letícya Lorrayne da Silva Soares; Francisca Louenny Cardoso Alves; Maria Acelina Martins de Carvalho; Josy Anteveli Osajima; Edson C. Silva-Filho
    Year: 2023
    Journal: International Journal of Biological Macromolecules
    DOI: 10.1016/j.ijbiomac.2023.124864
    ISSN: 0141-8130
  4. Title: Hydrogel Based on Nanoclay and Gelatin Methacrylate Polymeric Matrix as a Potential Osteogenic Application
    Authors: Danielle B. Andrade; Leticya L. S. Soares; Francisca L. A. Cardoso; Idglan S. Lima; Jhaemely G. V. Silva; Maria A. M. Carvalho; Maria Fonseca; Guilherme de C. Brito; Francisco Eroni Paz dos Santos; Josy Osajima et al.
    Year: 2023
    Journal: Journal of Functional Biomaterials
    DOI: 10.3390/jfb14020074
    ISSN: 2079-4983
  5. Title: Avanços Da Bioimpressão 3D Para A Medicina Regenerativa
    Authors: André Cardoso Tavares; Francisca Kaline Ferreira Pereira; Beatriz Lemos da Silva Loureiro; Evelle Rodrigues Sousa; Francisca Louenny Alves Cardoso
    Year: 2022
    Type: Conference abstract
  6. Title: O Uso De Células-Tronco Mesenquimais Como Tratamento Do Câncer E Sua Complexidade
    Authors: Francisca Kaline Ferreira Pereira; André Cardoso Tavares; Luísa Vitória de Sa Carneiro Souza; Francisca Louenny Alves Cardoso
    Year: 2022
    Type: Conference abstract
  7. Title: Uso De Células-Tronco Pluripotentes Induzidas Para Tratamento De Diabetes Mellitus
    Authors: Luísa Vitória de Sa Carneiro Souza; Paulo Renato de Oliveira Silva; Francisca Kaline Ferreira Pereira; Francisca Louenny Alves Cardoso
    Year: 2022
    Type: Conference abstract
  8. Title: Viabilidade Das Células-Tronco Mesenquimais Derivadas Da Medula Óssea Cultivadas Com Laponita
    Authors: Francisca Louenny Alves Cardoso; Danielle Benigno de Andrade e Silva; André Cardoso Tavares; Napoleão Martins Argolo Neto; Maria Acelina Martins De Carvalho
    Year: 2022
    Type: Conference abstract
  9. Title: Atividade Antifúngica Do Óleo Essencial De Cymbopogon Winterianus
    Authors: Francisco Vinicius Bezerra Oliveira; Francisca Louenny Alves Cardoso; Felipe de Carvalho Nunes; Sandiele Cantuario Sales; Tacyana Pires De Carvalho Costa; Kelly Maria Rêgo Da Silva
    Year: 2019
    Type: Conference abstract
  10. Title: Uso Da Nanopartícula De Laponita Para Diferenciação Celular Em Culturas De Células-Tronco Mesenquimais
    Authors: Francisca Louenny Alves Cardoso; Felipe de Carvalho Nunes; Francisco Vinicius Bezerra Oliveira; Pamela Benicio de Souza; Maryna De Oliveira Carneiro
    Year: 2019
    Type: Conference abstract

 

Ehsan Saburi | Molecular Biology | Life Sciences Innovation Award

Published on by Shen Awards

Dr. Ehsan Saburi | Molecular Biology | Life Sciences Innovation Award

Assistant Professor of Mashhad university of Medical Sciences, Iran.

Dr. Ehsan Saburi is an Assistant Professor at the School of Medicine, Mashhad University of Medical Sciences, specializing in Molecular Medicine. He holds a Ph.D. and has contributed significantly to research in areas such as stem cell therapy, COVID-19, and the molecular mechanisms of various diseases. Dr. Saburi has led numerous research projects, exploring the genetic and molecular aspects of health conditions like COVID-19, cancer, and autoimmune disorders. His work includes the investigation of gene polymorphisms, the therapeutic potential of cell therapy, and the effects of natural compounds on disease progression. Dr. Saburi’s research has been published in high-impact journals, demonstrating his commitment to advancing medical knowledge. His expertise in molecular medicine and his dedication to innovative research make him a strong candidate for the Best Researcher Award.

Profile
Education

Dr. Ehsan Saburi is an accomplished academic with a strong foundation in Molecular Medicine. He earned his Doctor of Philosophy (Ph.D.) in this specialized field, reflecting his deep commitment to advancing medical science. His educational journey is marked by rigorous training and research, equipping him with a profound understanding of molecular mechanisms and their applications in medicine. Dr. Saburi’s academic background is further enriched by his involvement in various research projects at the Mashhad University of Medical Sciences, where he continues to explore the frontiers of medical research. His education has provided him with the skills and knowledge necessary to contribute significantly to the scientific community, particularly in the areas of stem cell research, genetic studies, and the development of innovative medical therapies. Dr. Saburi’s educational achievements underscore his dedication to excellence in both teaching and research, making him a respected figure in his field.

Professional Experience

Dr. Ehsan Saburi is an accomplished Assistant Professor at Mashhad University of Medical Sciences, specializing in Molecular Medicine. With a Ph.D. in the same field, he has played a pivotal role in various research projects, particularly those focusing on the molecular mechanisms of diseases, stem cell therapy, and the impact of genetic polymorphisms on health outcomes. His professional experience is marked by leadership in numerous high-impact studies, including investigations into COVID-19, stem cell differentiation, and the protective effects of natural compounds on organ systems. Dr. Saburi has been instrumental in advancing research in molecular medicine through his extensive work on genetic factors influencing disease severity and innovative therapeutic approaches. His contributions to the academic community are further evidenced by his numerous publications in reputable journals and his active involvement in ongoing research projects aimed at improving health outcomes through molecular and genetic insights.

Research Interest

Dr. Ehsan Saburi’s research interests lie at the intersection of molecular medicine and regenerative medicine, with a particular focus on the therapeutic potential of stem cells and the molecular mechanisms underlying various diseases. His work extensively explores the use of adipose-derived mesenchymal stem cells (AD-hMSCs) in tissue regeneration, particularly in the context of osteogenic and chondrogenic differentiation. Dr. Saburi is also deeply involved in studying the genetic and molecular pathways related to chronic diseases, including cancer and autoimmune disorders. His recent projects have investigated the effects of various bioactive compounds, such as melatonin and curcumin, on mitigating disease symptoms and improving patient outcomes. Additionally, Dr. Saburi’s research includes examining the genetic factors that influence the severity of infectious diseases like COVID-19, aiming to contribute to the development of more effective treatments and vaccines. His multidisciplinary approach positions him at the forefront of translational medicine and therapeutic innovation.

Research Skills

Dr. Ehsan Saburi, an Assistant Professor of Molecular Medicine at Mashhad University of Medical Sciences, demonstrates extensive expertise in advanced molecular and cellular research. His skills encompass a wide range of scientific techniques, including genetic manipulation, stem cell research, and biochemical analysis. Dr. Saburi has led numerous research projects, particularly focusing on the genetic and molecular mechanisms underlying diseases such as cancer, COVID-19, and neurodegenerative disorders. His proficiency in designing and executing complex experiments is evidenced by his successful investigation of various signaling pathways, gene polymorphisms, and therapeutic effects of natural compounds. Additionally, Dr. Saburi is skilled in the use of bioinformatics tools for data analysis and interpretation, contributing to his ability to publish in high-impact journals. His collaborative approach and ability to manage multidisciplinary research teams further highlight his research capabilities, making him a valuable asset in the field of molecular medicine.

Awards and Recognition

Dr. Ehsan Saburi, an accomplished Assistant Professor at Mashhad University of Medical Sciences, has garnered significant recognition for his contributions to molecular medicine. His extensive research on stem cell therapies, COVID-19, and the molecular mechanisms underlying various diseases has earned him numerous accolades. Dr. Saburi’s innovative work on the protective effects of melatonin and curcumin in disease models has been widely acknowledged in the scientific community. He has received several prestigious awards for his groundbreaking research, including the Best Researcher Award from Mashhad University. His publications in high-impact journals and his involvement in pioneering research projects have further solidified his reputation as a leading scientist. Dr. Saburi’s commitment to advancing medical science continues to be recognized through various honors and awards, underscoring his impact on the field and his dedication to improving human health.

Conclusion

Dr. Ehsan Saburi is a highly capable and dedicated researcher with significant contributions to molecular medicine and COVID-19 research. His extensive research activities, leadership in numerous projects, and commitment to advancing medical science make him a strong candidate for the Best Researcher Award. However, to enhance his candidacy further, focusing on the impact of his publications, fostering international collaborations, and pursuing more innovative research avenues would be beneficial.

Publications Top Notes

  1. Title: Advances and challenges of the cell-based therapies among diabetic patients
    Authors: Raoufinia, R., Rahimi, H.R., Saburi, E., Moghbeli, M.
    Journal: Journal of Translational Medicine
    Year: 2024
    Citations: 1
  2. Title: Leveraging stem cells to combat hepatitis: a comprehensive review of recent studies
    Authors: Raoufinia, R., Arabnezhad, A., Keyhanvar, N., Namdar, A.B., Rahimi, H.R.
    Journal: Molecular Biology Reports
    Year: 2024
  3. Title: Hematological changes due to malaria – An update
    Authors: Naser, R.H., Rajaii, T., Farash, B.R.H., Sadabadi, F., Saburi, E.
    Journal: Molecular and Biochemical Parasitology
    Year: 2024
  4. Title: Apoptotic effects of biodentine, calcium-enriched mixture (CEM) cement, ferric sulfate, and mineral trioxide aggregate (MTA) on human mesenchymal stem cells isolated from the human pulp of exfoliated deciduous teeth
    Authors: Nazemi Salman, B., Mohebbi Rad, M., Saburi, E.
    Journal: Minerva Dental and Oral Science
    Year: 2024
  5. Title: Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy
    Authors: Raoufinia, R., Rahimi, H.R., Keyhanvar, N., Foroudi, S., Saburi, E.
    Journal: Stem Cell Reviews and Reports
    Year: 2024
    Citations: 1
  6. Title: Role of microRNAs in tumor progression by regulation of kinesin motor proteins
    Authors: Nasimi Shad, A., Fanoodi, A., Maharati, A., Forouzanfar, F., Moghbeli, M.
    Journal: International Journal of Biological Macromolecules
    Year: 2024
  7. Title: Therapeutic potential of lipid-lowering probiotics on the atherosclerosis development
    Authors: Saadh, M.J., Bazghandi, B., Jamialahmdi, H., Esmaeili, S.-A., Saburi, E.
    Journal: European Journal of Pharmacology
    Year: 2024
  8. Title: Synthesis of bone biocompatible implants using human adipose-derived mesenchymal stem cells (hADMSCs) and PCL/laminin scaffold substrate
    Authors: Zeydari, D., Karimi, E., Saburi, E.
    Journal: Iranian Journal of Basic Medical Sciences
    Year: 2024
    Citations: 2
  9. Title: Genetic landscape of hearing loss in prelingual deaf patients of eastern Iran: Insights from exome sequencing analysis
    Authors: Alerasool, M., Eslahi, A., Vona, B., Niknezhad, H.T., Mojarrad, M.
    Journal: Clinical Genetics
    Year: 2024
  10. Title: Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics
    Authors: Raoufinia, R., Rahimi, H.R., Abbaszadeh, M., Khazaei, M., Avan, A.
    Journal: Current Pharmaceutical Design
    Year: 2024